The vertebrate heart contains two myosin heavy chain isoforms, av and ,B, which are differentially expressed. To establish a murine model for gene-targeting experiments, we defined the precise temporal expression of the myosin isoforms during cardiogenesis and obtained quantitative measurements of cardiac performance. The relative levels of the a-and 3-cardiac transcripts were determined by isolating the RNA from the hearts of CD-1 mice during development and hybridizing the preparations to probes that detect specifically the aor 3-cardiac myosin heavy chain mRNAs. The data indicate that, although both isoforms are present from the onset of cardiogenesis, the P-isoform predominates during embryogenesis and fetal development. This relation is reversed after the first day of life with a significant drop in the absolute transcript levels during the switch; an a/p ratio of 16:1 is maintained in the neonate, and the relatively high levels of the a-transcript remain throughout the adult stages. To be able to make functional comparisons between normal and transgenic mice, we obtained indexes of myocardial function in isolated retrogradely perfused and in work-performing heart preparations in normal and hypodynamic mouse hearts. We found that the physiology of the mouse heart is similar to the rat heart in that we observed a positive staircase in the force-frequency relation of the mouse Langendorff preparation. We also saw contractile responses of more than twice control induced by paired stimulation and persistent postextrasystolic potentiation. As is the case for the rat, in the work-performing mouse heart, afterload (Starling resistance, pressure) changes produced a steeper Starling function curve than did changes in preload (volume, venous return). (Circulation Research 1991;69:1742-1750 In the mouse, as in most mammals and vertebrates, the major contractile protein by mass of skeletal and cardiac muscle is the myosin heavy chain (MHC), which is represented in the vertebrate genome as a family.1-4 The number of members varies depending on the particular animal, but each member encodes a unique protein isoform that is expressed in a development-specific, tissue-specific, and, in some cases, a muscle-type-specific manner.5,6 The patterns of expression of the isoforms and the sequence differences that underlie the different pro-From the Division of Pediatric Cardiology (W.A.N.) and the
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The vertebrate heart contains two myosin heavy chain isoforms, av and ,B, which are differentially expressed. To establish a murine model for gene-targeting experiments, we defined the precise temporal expression of the myosin isoforms during cardiogenesis and obtained quantitative measurements of cardiac performance. The relative levels of the a-and 3-cardiac transcripts were determined by isolating the RNA from the hearts of CD-1 mice during development and hybridizing the preparations to probes that detect specifically the aor 3-cardiac myosin heavy chain mRNAs. The data indicate that, although both isoforms are present from the onset of cardiogenesis, the P-isoform predominates during embryogenesis and fetal development. This relation is reversed after the first day of life with a significant drop in the absolute transcript levels during the switch; an a/p ratio of 16:1 is maintained in the neonate, and the relatively high levels of the a-transcript remain throughout the adult stages. To be able to make functional comparisons between normal and transgenic mice, we obtained indexes of myocardial function in isolated retrogradely perfused and in work-performing heart preparations in normal and hypodynamic mouse hearts. We found that the physiology of the mouse heart is similar to the rat heart in that we observed a positive staircase in the force-frequency relation of the mouse Langendorff preparation. We also saw contractile responses of more than twice control induced by paired stimulation and persistent postextrasystolic potentiation. As is the case for the rat, in the work-performing mouse heart, afterload (Starling resistance, pressure) changes produced a steeper Starling function curve than did changes in preload (volume, venous return). (Circulation Research 1991; 69:1742 -1750 In the mouse, as in most mammals and vertebrates, the major contractile protein by mass of skeletal and cardiac muscle is the myosin heavy chain (MHC), which is represented in the vertebrate genome as a family.1-4 The number of members varies depending on the particular animal, but each member encodes a unique protein isoform that is expressed in a development-specific, tissue-specific, and, in some cases, a muscle-type-specific manner. 5, 6 The patterns of expression of the isoforms and the sequence differences that underlie the different pro-teins have been delineated in rabbits,7 rats,8 chickens,9 hamsters,10 humans," and baboons. 12 There are three myosin isoforms present in the vertebrate heart, the relative amounts depending on the developmental stage, the hormonal status, the region of the heart, and the particular species examined. These isoforms were named V,, V2, and V3 on the basis of their electrophoretic migration pattern under nondenaturing conditions in polyacrylamide gels.'3 Later analyses showed that two proteins termed a-and fl-cardiac MHC composed these isoforms: Vl=aa, V2=af3, and V3=/3f3. Although they are termed "cardiac isoforms," both proteins are detectable in other tissues.'4 The /-cardiac isoform, in particular, is found in large concentrations in slow twitch fibers and appears to be the "slow" isoform of skeletal muscle.1' In the rat, which has been the most extensively studied small mammal, the f3-isoform is predominant during embryonic and fetal development. However, soon after birth the a-isoform predominates in both the ventricle and atrium.10,16 This developmental switch is thought to be mediated, at least partially, by thyroid hormone levels,17-19 and several putative thyroid responsive elements have been localized in the genes of humans20 and rats.21 These isoform shifts in the cardiac compartment may be artificially manipulated by hormonal induction, by drug administration, or by surgically induced pressure overload. In small mammals such as the rat or rabbit, banding of the aorta quickly results in a significant hypertrophy and a shift from the Vt to V3 myosin in the left ventricle is observed in a matter of days.22,23 This abnormal gene expression in the hypertrophied muscle is thought to be a compensatory response in that mechanical efficiency is improved24 and energy is spared.25 At the same time, the time to peak tension during each systole is increased. 26 The human ventricle does not undergo this type of transition since, in the adult, the myosin is already primarily V3. However, an isoform shift does occur in the human atria; although a mixture of MHC isoforms is normally present, an upregulation of the n3-cardiac form is observed during left atrial hypertrophy. 27, 28 There is extensive evidence that the speed of contraction is dependent on the particular MHC isoform present,29-31 and it is believed that the switch may play a role in the heart's functional adaptation to chronic overload.32 Despite the preponderance of biochemical evidence, the exact nature of the relation between the MHC isoforms and the contractile behavior of the heart has not been delineated. By necessity, all of the studies have depended on circumstantial evidence. That is, a pathological process, or physiological perturbation, is accompanied by changes in the MHC isoforms, but whether the isoform change is directly responsible for and sufficient to cause the alteration in cardiac behavior remains unproven.
It is likely that many of the genetic mutations in the contractile proteins will significantly affect the development or function of the heart. This may explain the very small number of mutations described so far that affect the myocardium either in human or animal models. 33 With the advent of gene-targeting technology in the mouse, the use of directed gene modification becomes feasible in mammals. With the use of homologous recombination, it is now possible to target a gene of interest and ablate it or introduce defined mutations34-38 into the animal's germ line to determine the function, or functions, of a specific gene product. Thus, lossor gain-of-function mutations can now be induced and studied directly in the whole animal. We believe it likely that ablation or modification of the MHC that is expressed in the adult myocardium will lead to recognizable deficits at the molecular, cytological, biochemical, and functional levels. 39, 40 Quantitative measurements of the status of myocardial function and of changes in function produced by experimental conditions are difficult to obtain, and the difficulties increase when heart-to-heart comparisons are required. In animal experiments, quantitation has been attempted by direct measurements of tension or pressure and their rates of change in papillary muscles and isolated hearts, respectively.4' However, experiments in whole hearts (Langendorif) and working-heart preparations become more restrictive as the size of the hearts decreases. Although numerous studies of functional aspects in most mammalian species are available, very little information has been published about the functional physiology of the murine heart, because the mouse heart is very small (heart weight, 80-120 mg).
This report initiates a definition of the murine system, the eventual goal being to determine the exact relations between the MHC isoforms and the contractile behavior of the heart by making directed mutations in the cardiac loci. We define the MHC isoforms expressed during murine cardiogenesis and their relative levels. We also demonstrate that measurement of cardiac function can be obtained in both retrogradely perfused and work-performing hearts.
Materials and Methods Animals
CD-1 prenatal and postnatal mice were used for the developmental study. The morning of vaginal plug was counted as postcoital (p.c.) day 1 and the day of birth, as p.c. day 20. Animals were anesthetized with chloroform and killed by cervical dislocation. Hearts were removed under a dissecting microscope and rinsed in phosphate-buffered saline solution. Tissues were stored in liquid nitrogen until use. Adult Swiss mice (80-120 days old) were used for the isolated perfused heart preparation ( Table 1) . The animals were anesthetized intravenously with 30 mg/kg sodium pentobarbital and were heparinized intraperitoneally (5,000 USP units/kg). After the chest was opened, the heart was removed and immediately suspended in a Langendorff apparatus for retrograde perfusion with warm Krebs-Henseleit solution (KHS) (KHS [mM]: Na+ 145, K' 5.9, Ca2+ 2.5, MgSO4 1.2, Cl-119, HCO3-25, H2P04-1.2, EDTA 0.5, and glucose 5.5). Hearts were stored in liquid nitrogen after measurements were completed.
RNA Isolation
Total cellular RNA was isolated from embryonic, fetal, neonatal, and young and old adult hearts by using RNAzol (Cinna Biotecx, Friendswood, Tex.). The tissue was homogenized with a Tissuemizer (Tekmar Co., Cincinnati, Ohio) in a tube containing RNAzol; the manufacturer's protocol was followed with the addition of a precipitation step with 0.1 vol of 3 M Tris (pH 7.4) and 2 vol ethanol. The RNA was resuspended in water, and the concentration determined by the optical density at 260 nm. The integrity and purity of the RNA was confirmed by gel electrophoresis and the optical density profiles.
Nucleic Acid Blots
Twofold serial dilutions of the RNAs, starting with 33 40 Time of one half relaxation (msec) 24 33 bridized to a specific ,3and then a-cardiac MHC oligonucleotide. Hybridizations were performed in 4x saline sodium citrate (SSC) (lx SSC=0.15 M sodium chloride, 0.015 M sodium citrate), 1% sodium dodecyl sulfate (SDS), 100 mg/ml denatured sonicated salmon sperm DNA, and 5 x Denhardt's solution at 50°C for 8 hours. The filters were washed twice for 10 minutes in 0.5x SSC and 1% SDS at 60°C, and the autoradiographs were exposed at -70°C with Kodak X-Omat film by using Cronex Lighting Plus screens (Du Pont, Wilmington, Del.) and developed after 6 hours. To determine the relative RNA levels, the signals were quantitated by laser densitometry (model GS-300 transmittance/reflectance scanning densitometer, Hoefer Scientific Instruments, San Francisco). Densitometry was performed on exposures in which spot intensity fell within the linear range of the film. The blot was stripped by two incubations in 0.01x SSC and 90% formamide at 60°C for 10 minutes each and rehybridized with the next probe. In all cases, the probe was labeled to a specific activity of 1 x 107 dpm/pmol by using [y-32P]ATP (specific activity, 6,000 Ci/mmol; New England Nuclear, Boston) and thyroxine (T4) polynucleotide kinase.
Oligonucleotides
By using the 3' untranslated region, oligonucleotide probes specific for a-and /3-cardiac MHC14 were synthesized on a DNA synthesizer (Applied Biosystems, Inc., Foster City, Calif.) and purified on a 12% acryl-amide-8 M urea DNA sequencing gel. The gel-cut oligomer was recovered by overnight extraction into 10 mM Tris-HCI (pH 7.4)-1 mM EDTA at 37°C and was precipitated with 100 mM NaCl and 8 vol ethanol at -70°C for 45 minutes. The DNA was recovered by centrifugation at 35,000 rpm using a Beckman SW40t rotor (Beckman Instruments, Fullerton, Calif.) at 4°C for 45 minutes. By using T4 polynucleotide kinase, oligonucleotide probes were end-labeled with [y-32P]ATP. Unincorporated nucleotides were separated by fractionation on a Sephadex G-50 column (Pharmacia LKB Biotechnology Inc., Piscataway, N.J.).
Production of Hypothyroid Mice
Healthy adult C57BL/6J (80-125 -day-old) mice were put on a commercial diet (Teklad Premier, Madison, Wis.) containing 0.15% 5-propyl-2-thiouracil (PTU) for 4 weeks to decrease serum levels of T4. Serum T4 levels were determined by radioimmunoassay.
Isolated Perfused Mouse Heart
The basic perfusion system42.43 for the work-performing and Langendorff preparations required several adjustments for the smaller mouse hearts as follows.
Retrogradely perfused Langendorffpreparation. The isolated intact mouse heart was suspended via its ascending aorta on a 20-gauge cannula and was retrogradely perfused from a heated storage cylinder with 37°C oxygenated KHS. The cylinder containing the buffer was positioned above the heart to produce a constant pressure of 55 mm Hg for the retrograde perfusion of the coronary arteries. Coronary flow was measured with an electronic balance. A very thin polyethylene catheter (PE90) was inserted through a pulmonary vein opening of the left atrium and through the mitral valve (during its opening) into the left ventricle. The catheter was pushed through the apical wall of the left ventricle until the flanged end of the catheter rested against the inner wall of the ventricle. It was then connected to a high-pressure transducer to record left intraventricular pressure and its derivative, dP/dt. Additional parameters such as electrocardiogram, heart rate, and temperature were monitored on a polygraph (model P7, Grass Instrument Co., Quincy, Mass.). At the end of each experiment the hearts were frozen in liquid nitrogen until subsequent analysis of the RNA.
Anterogradely perfused working-heart preparation. This preparation was obtained by first preparing the retrogradely perfused heart: after perfusion was well established, a 20-gauge cannula was tied through the pulmonary vein into the left atrium. The retrograde perfusion was then switched to an anterograde perfusion. Left atrial pressure was measured through a sidearm of this cannula with a pressure transducer (P-23 XL, 50-300 mm Hg range; Statham, Oxnard, Calif.). Left ventricular pressure and aortic pressure were recorded through high-range Statham pressure transducers (P-23 AC, 0-750 mm Hg range). The venous return was continuously monitored by an . Coronary flow and aortic flow were monitored during the experiments. Aortic resistance was varied by way of a second adjustable micrometer for changes in afterload. One milliliter of air in a chamber (Windkessel) above the aortic valve provided the necessary "arterial" elastic recoil required for maintenance of coronary flow. The left atrial and aortic cannulas were constructed from stainless steel, which permitted the simultaneous recording of a lead I-type electrocardiogram. The R waves of the electrocardiogram were used to instantaneously compute heart rate, which was recorded on a polygraph. The same electrodes served as an external pacemaker to govern heart rate and to produce force-frequency changes by including a stimulator and a stimulus isolation unit in the circuit.
Results

Developmental Expression of the Cardiac Myosin Heavy Chain mRNAs in the Mouse Heart
A precise temporal definition of the cardiac transcript expression in the heart is necessary to establish a descriptive rationale for the future gene-targeting experiments. Previously, we have developed oligonucleotide probes that are able to distinguish between the a-and fl-cardiac mRNA transcripts14 and that show absolute specificity for their respective cognate sequences. These probes were used to determine the relative levels of the two cardiac MHC transcripts in the mouse hearts during the embryonic, fetal, neonatal, and adult stages of development. RNA was isolated from the hearts, blotted onto nitrocellulose, hybridized to the fi-or a-cardiac oligonucleotide probes, and quantitated by laser densitometry. The autoradiogram is shown in Figure 1 . Although both isoforms are present from the onset of cardiogenesis, the f-cardiac MHC predominates during the early such as the rat, could be adopted successfully for the mouse. All hearts were initially perfused as Langendorff preparations at either 37°C or 35°C. The hearts beat spontaneously at a rate of 300-400 beats/min at a temperature of 37°C. Coronary flow was between 0.9 and 2 ml/min, left intraventricular pressure (IVP) ranged between 50 and 75 mm Hg, and +dP/dt ranged between 1,500 and 2,500 mm Hg/sec. The hearts were stable for 1-6 hours, a period of time long enough to determine all functional parameters of interest. Information concerning the functional status of cardiac contraction in the Langendorif preparations was derived by determining the force-frequency relation. These force-frequency curves were done at the lower temperature (35°C) to prevent the occurrence of extra beats. The murine hearts demonstrated a positive staircase, or treppe (Figure 3 ): the increase in heart rate produced a strong increase in IVP and also in contractility (+ dP/dt). The maximum achievable contractile force obtained with paired stimulation, in which a continuously interpolated extra stimulus produced a continuous postextrasystolic potentiation was 115% and 125% over control.
The tracing used to calculate the contractile parameters is shown in Figure 4 . The individual values are lower in the Langendorff preparation when compared with a work-performing heart preparation (compare Figures 4 and 5 and Table 1 ). As described in "Materials and Methods," Langendorff retrogradely perfused mouse hearts were converted into anterogradely perfused work-performing hearts by channeling the venous return through a pulmonary vein into the left atrium and left ventricle. The cardiac output (which equaled venous return) was calculated by adding coronary flow and aortic outflow. A set of tracings from a typical murine working heart is shown in Figure 5 . At a heart rate of 380 beats/min aortic mean pressure was 45 mm Hg, IVP was 100/-10 mm Hg, +dP/dt was 3,050 and -dP/dt was 2,625 mm Hg/sec, cardiac output was 4.6 ml/min, and stroke volume (cardiac output/heart rate) was 12 ,ul. The working murine heart's responses to variations in preload and afterload were examined. We first attempted to increase cardiac output by increasing venous return (preload) until + dP/dtm. no longer changed or began to fall ( Figure 6 ). In the example shown in Figure 6 , venous return was changed from 4.0 to 6.2 ml/min; the maximal amount of volume work tolerated by this heart was 310 mm Hgxml/min.
Starting from the same baseline, aortic resistance (Starling resistance, afterload) was also increased stepwise until the heart showed signs of failure: in this example from 45 to 70 mm Hg. The maximal amount of pressure work (filled circles in Figure 6 ) tolerated was 290 mm Hgxml/min. Pressure load produced a slope 2.1 times that observed for volume load, which is consistent with data obtained in other working heart models. To confirm that we could, in fact, delineate a normal (healthy) heart from one that was in some way stressed, or in failure, we repeated these procedures with a series of normal and failing (hypodynamic) hearts. By increasing afterload, or overload (see "Materials and Methods"), the hearts were severely stressed, as measured by an increase in the end-diastolic and left atrial pressures, as well as a decrease in contractility. The comparative values are shown in Table 1 and illustrate that our measurements do detect a failing myocardium.
Hypothyroidism, in the rodent models, has been shown to effect an MHC isoform switch from the a-cardiac protein to the fetal, P-cardiac protein.1844-46
Accompanying this switch a hypodynamic heart is observed. We wished to confirm that a hypothyroid condition would effect a similar switch in the murine model and that perturbation of the heart's functional state, as measured by the techniques outlined above, could be detected. Hypothyroidism was induced by dietary treatment with PTU and confirmed by radioimmunoassay. A 4-week feeding regimen ("Materials and Methods") resulted in blood serum levels decreasing from 4.5 gg/dl on day 1 to <0.4 gg/dl on day 28 of the diet.
When the hearts from control and PTU-treated animals were examined for relative levels of the a-and /3-cardiac MHC transcripts, we found that the mouse hearts responded in the expected manner, and the switch to the fetal MHC transcript appeared to be essentially complete in the hypothyroid animals (e.g., Figure 7A ).
The physiological parameters of these hearts were determined using a working-heart preparation. For each trial an untreated and PTU-treated pair of mice were killed, and the hearts were perfused as described in "Materials and Methods." After a 1-hour perfusion, RNA was isolated from both of the hearts and the relative levels of the two MHC transcripts were determined. An example of these data, together with the physiological parameters from the same hearts, is shown in Figure 7 . The data show the magnitude of the transcript switch and the accompanying change in the functional behavior of these hearts. The heart derived from the hypothyroid animal is significantly altered in terms of its contractile mechanics, with significantly prolonged time to peak and relaxation times. More complete data obtained in multiple separate trials are shown in Table 2 , and using the developed techniques, differences in the functional end points of these hypodynamic hearts are clearly observed.
Discussion
Both the relative and absolute amounts of the cardiac MHC isoforms are developmentally regulated. The results presented here demonstrate that in the mouse, as in other small mammals such as rat or rabbit. the cardiac MHC transcript that is the most abundant during the embryonic and fetal life is the /3-isoform. It is evident from the data in Figure 2 that immediately preceding birth there is a significant decrease in the steady-state levels of both the a-and *The normal and hypothyroid hearts had different intrinsic heart rates. All contractile parameters were determined on paced hearts of 340 beats/min. The measurements were carried out in all preparations under conditions of equal preload and afterload. Thyroxine levels in the propylthiouracil-treated hearts were <0.4 ,ug/dl. ,3-transcripts (p.c. days [18] [19] . After birth, the fl-transcript levels never recover, whereas the a-cardiac mRNA levels approach those observed for the fl-transcripts at their peak (p.c. days [16] [17] . We noted a slight but reproducible drop in relative transcript levels when young adult (60-day-old) and old adult (300-day-old) hearts were compared (Figure 1) . No compensatory fl-transcript increase was observed and, apparently, in the mouse the absolute MHC transcript level decreases slightly during the aging process.
It is interesting to speculate on the role that the a-cardiac isoform might play during embryonic and fetal development. It is constitutively expressed in the developing atria47 and, although during this period in myocardial development the a-cardiac levels appear to be low when compared with the fl-cardiac mRNA transcripts, we do not yet know whether moderate levels of expression in other, nonatrial areas of the developing heart, such as the conduction system cells,48 might occur. Alternatively, low levels of a-transcripts in the generalized myocardium could play an important or even critical role during development and differentiation. The ability to target a specific murine gene and ablate its expression or to create a polypeptide with a known mutation allows us to now ask such questions directly. That is, the a-cardiac locus in the mouse can be ablated and the phenotypic and physiological consequences of the mutation can be assessed directly. In addition to ablation studies, the gene-targeting technologies offer the ability to make directed animal models of disease. For example, a point mutation of the fl-cardiac isoform has been detected in all individuals affected with familial hypertrophic cardiomyopathy from a large kindred, suggesting that a critical function of myosin is disrupted by this mutation.39,40 The identical mutation could be created in the murine model for which critical structure and function questions can be studied directly and more easily.
The analyses of such animals should include, in addition to the molecular genetic, cytochemical, histochemical, and biochemical determinations, a quantitative, functional analysis of the mouse heart, and to this end we describe in this study the functional characteristics of retrogradely and anterogradely perfused heart preparations. Because of the small size of the mouse heart (often less than 100 mg), whole murine heart preparations are technically difficult. However, we were able to record. in the Langendorff preparation, parameters reflecting the physiological status of contraction and contractility (rate of contraction and relaxation of the normal and the hypodynamic mouse heart ( Figure 4 , Table 1 ). It was possible to elicit force-frequency and postextrasystolic potentiation responses that compared well with those obtained for dog hearts studied in SitU.49 Particularly, the parameters of relaxation will be helpful in the subsequent analyses of the animals generated by the gene-targeting studies. In the anterogradely perfused work-performing mouse hearts, Starling function curves were obtained to gain insight into the status and the total range of cardiac function of an individual heart, particularly the limits to which it could be loaded with maximal work loads. Alterations of both preload and afterload allowed us to assess the limits of the myocardial functional reserve available in the murine heart, since volume work done during preload changes and the pressure work done during afterload changes put very different strains on the heart. We found, in the mouse heart, as others have in hearts of other species,5051 that pressure load produced about two to three times more work than did volume load ( Figure 6 ). It should be noted that when comparisons of this type are made, an identical cycle length must be maintained so that the positive inotropic effects of activation produced by differences in heart rate are avoided. We think it very likely, on the basis of the data presented in Tables 1 and 2, that functional comparisons between individual control hearts and hearts from mice with genetic alterations that might affect a functional end point can be successfully carried out using, where appropriate, the developed methodologies.
In our hands the mouse heart preparations were stable during the procedures in which functional comparisons were obtained. Hearts were routinely frozen after all measurements were completed; the RNAs were isolated and their integrity tested. mRNA integrity is exquisitely sensitive to cell death and lysis. No MHC mRNA degradation was noted, although a variable 10-20% decrease in the overall transcript levels was sometimes observed (data not shown). These data are consistent with the stable physiological, functional measurements made during the 1-6-hour period and indicate that the integrity of the MHC transcript pool was not materially affected by the perfusion procedures.
With the development of a working murine heart model and the ability to obtain responses of functional parameters to different stimuli, it becomes possible to determine the physiological end points of a mutated myocardium. These functional end point determinations, coupled with the ability to manipulate the relevant genes, should allow us, in vivo, to understand how changes in myosin isoform expression participate in normal development and in myocardial responses to various cardiomyopathies.
